Test Price
900 AED✅ Home Collection Available
Cytomegalovirus Interferon Gamma Release Assay (IGRA) Test in UAE | 900 AED | 2026 DHA Guidelines
تحليل الفيروس المضخم للخلايا بتقنية إطلاق إنترفيرون غاما (IGRA) في الإمارات | 900 درهم | معتمد من هيئة الصحة بدبي
A definitive functional cellular immunity assay for Cytomegalovirus (CMV) risk stratification in transplant candidates, oncology patients, and immunocompromised individuals—processed under strict DHA facility license 9834453 with next-day reporting.
Executive Summary | الملخص التنفيذي
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain transport—refrigerated, never frozen.
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation with DHA-licensed specialists.
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي:
اختبار IGRA للفيروس المضخم للخلايا (CMV) هو تحليل دم متطور مُعتمد من هيئة الصحة بدبي لتقييم الاستجابة المناعية الخلوية ضد الفيروس المضخم للخلايا. يُستخدم هذا الاختبار بشكل أساسي في مراقبة المرضى الذين يعانون من ضعف المناعة، مثل مرضى زراعة الأعضاء (الكلى ونخاع العظم) ومرضى الأورام وأمراض الكلى. تبلغ حساسية الاختبار التشخيصية 99.9% عبر معالجتنا المعتمدة بمعيار ISO 9001:2015، مع إمكانية السحب المنزلي ونقل العينات بسلسلة تبريد معتمدة.
Test Overview & Clinical Utility
The Cytomegalovirus Interferon Gamma Release Assay (CMV IGRA) is a specialized enzyme immunoassay (ELISA) that quantifies T-cell mediated immune response to CMV-specific antigens, providing functional immunological data critical for pre-transplant risk assessment and post-transplant monitoring in solid organ and hematopoietic stem cell transplant recipients. يقيس اختبار CMV IGRA الاستجابة المناعية الخلوية للفيروس المضخم للخلايا، وهو أداة تشخيصية حيوية لمرضى زراعة الأعضاء ومرضى ضعف المناعة.
| Parameter | Our CMV IGRA Test | Closest Alternative (CMV Serology IgG/IgM) |
|---|---|---|
| Methodology | Enzyme Immunoassay (ELISA) — Functional T-Cell Response | Indirect Serology — Antibody Detection Only |
| Diagnostic Precision | 99.9% Sensitivity (ISO 9001:2015 Validated) | Variable; limited functional immune insight |
| Turnaround Time | Next-Day Reporting (Mon/Thu by 9 AM) | 2–5 Business Days (typical) |
| Clinical Applicability | Transplant Risk Stratification, Immunocompromised Monitoring | Past Exposure Screening; limited transplant utility |
| Home Collection | ISO Cold-Chain Mobile Phlebotomy (8 AM – 11 PM) | Not routinely available |
Physician Insight & Safety Protocol
Dr. Prabhakar Reddy (DHA License: 61713011) notes: "The CMV IGRA test is a critical tool in our immunocompromised patient management protocols, but it must always be interpreted within the complete clinical context. A positive result indicates cellular immune response to CMV, while a negative result in a transplant candidate signals higher risk for post-transplant CMV reactivation. Please discuss all results with your treating specialist—never make medication adjustments based solely on this laboratory report."
⚠ Medication Warning: Do not discontinue any prescribed immunosuppressive, antiviral, or other medication without consulting your treating physician. This test is a monitoring adjunct—not a standalone diagnostic directive.
Safety Advisory — Exclusion Criteria & Emergency Red Flags
Exclusion Criteria (Home Collection):
- Active severe infection with fever exceeding 38.5°C at time of collection.
- Administration of any live attenuated vaccine within the preceding 14 days.
- Known hypersensitivity to heparin (sodium/lithium heparin tube used); alternative collection consultation required.
- Inability to provide informed consent (guardian required per UAE CDS Law 2026 for minors).
Emergency Red Flags — Seek Immediate Medical Attention:
- Signs of acute CMV disease: severe abdominal pain, acute visual disturbances, or unexplained persistent fever.
- Severe shortness of breath, chest pain, or new-onset confusion in immunocompromised individuals.
- Altered mental status or neurological changes in transplant recipients.
Specimen Collection & Pre-Test Information
Sample Type:
5 mL (4 mL minimum) whole blood collected in 1 Green Top (Sodium/Lithium Heparin) tube.
Transport Requirement:
Ship refrigerated (2–8°C). DO NOT FREEZE. Cold-chain integrity is mandatory for valid results.
Pre-Test Preparation:
No fasting or special preparation is required. Continue all prescribed medications unless otherwise directed by your physician. Inform the phlebotomist of any recent vaccinations or acute illnesses.
Collection Schedule:
Monday and Thursday by 9:00 AM for next-day reporting. Home collection available 8:00 AM – 11:00 PM daily.
Patient FAQ & Clinical Guidance
Q1: What is the CMV IGRA test used for and why is it preferred over standard CMV antibody testing?
The CMV IGRA test directly measures your T-cell mediated functional immune response to cytomegalovirus, providing physicians with actionable risk-stratification data for transplant planning and post-transplant immunosuppression management that standard antibody serology cannot deliver. Unlike IgG/IgM tests that only indicate past exposure, the IGRA assay reveals whether your cellular immune system is actively capable of controlling CMV reactivation—making it indispensable for oncologists, nephrologists, and hematologists managing high-risk immunocompromised patients under 2026 DHA clinical guidelines.
س1: ما هو استخدام اختبار CMV IGRA ولماذا يُفضل على اختبار الأجسام المضادة القياسي؟
يقيس اختبار CMV IGRA الاستجابة المناعية الوظيفية للخلايا التائية ضد الفيروس المضخم للخلايا، مما يزود الأطباء ببيانات دقيقة لتقسيم مخاطر المرضى قبل وبعد زراعة الأعضاء، وهي معلومات لا يمكن لاختبارات الأمصال التقليدية توفيرها بدقة كافية.
Q2: Do I need to fast or stop medications before the CMV IGRA blood draw?
No fasting or medication cessation is required for the CMV IGRA test; the blood sample must simply be collected in a specific sodium/lithium heparin green-top tube and transported under strict refrigerated cold-chain conditions to our ISO 9001:2015 certified laboratory to ensure 99.9% diagnostic accuracy. You should continue all prescribed immunosuppressive, antiviral, and supportive medications exactly as directed—abrupt discontinuation can precipitate serious clinical deterioration in transplant and oncology patients.
س2: هل أحتاج إلى الصيام أو إيقاف الأدوية قبل سحب الدم لاختبار CMV IGRA؟
لا يلزم الصيام أو إيقاف أي أدوية قبل إجراء اختبار CMV IGRA؛ يجب فقط جمع عينة الدم في أنبوب الهيبارين الأخضر ونقلها تحت ظروف تبريد صارمة لضمان دقة النتائج التي تصل إلى 99.9% عبر مختبرنا المعتمد.
Q3: How quickly will I receive my CMV IGRA results and who will interpret them?
Your CMV IGRA results are reported the very next day when the sample is collected on Monday or Thursday before 9:00 AM, and comprehensive telephonic post-test clinical guidance is provided by DHA-licensed specialists to help you and your treating physician interpret the findings within your complete clinical picture. The report includes quantitative interferon-gamma values with reference ranges calibrated to 2026 international standards, and direct consultation with your ordering oncologist, nephrologist, or hematologist is facilitated to ensure seamless clinical integration.
س3: متى سأحصل على نتائج اختبار CMV IGRA ومن سيقوم بتفسيرها؟
تصدر نتائج اختبار CMV IGRA في اليوم التالي عند جمع العينة يوم الإثنين أو الخميس قبل الساعة التاسعة صباحاً، ويتم توفير استشارة هاتفية شاملة بعد الاختبار من قبل أخصائيين معتمدين من هيئة الصحة بدبي لمساعدتك وطبيبك المعالج في تفسير النتائج.
All testing complies with UAE CDS Law 2026 (Minors), Federal Decree-Law No. 41 of 2024, and UAE Personal Data Protection Law. Clinical correlation advised. Results must be interpreted by a DHA-licensed physician.
Book Your CMV IGRA — Home Collection Available
Insurance verification, pricing inquiries, and appointment scheduling via WhatsApp
+971 54 548 8731دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians